November is RXPC court date , some say that bk soon follows but I think it's the other way around. This is not a dead patent because if it was, any company could buy the patent for a small fee without inheriting the debt. muliti m dollar deals being worked with pharma comp. behind the scenes. gonna make the current debt look like peanut money.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.